Hepatobiliary Surgery and Nutrition

Article	Citations
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)	73
Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma	54
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional O	54
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?	43
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights	38
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease	35
Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians	35
Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection	32
Optimization of the future remnant liver: review of the current strategies in Europe	30
Biliary complications after liver transplantation: current perspectives and future strategies	29
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients	28
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy	28
A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis	27
Diagnosis-related Groups (DRG) pricing and payment policy in China: where are we?	25
Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma	24
Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients	23
An overview of the Chinese healthcare system	23
When a new definition overhauls perceptions of MAFLD related cirrhosis care	22
Cholangiocarcinoma: a review of the literature and future directions in therapy	22
The gut-liver axis as a target of liver disease management	17
Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses	17
Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need	17
The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study	16
Liver venous deprivation: a bright future for liver metastases—but what about hepatocellular carcinoma?	15
Machine learning predicts unpredicted deaths with high accuracy following hepatopancreatic surgery	15

Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice	15
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study	14
Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study	14
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	14
A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus	14
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future	13
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	13
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity	13
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries	13
The internet hospital: how to combine with traditional healthcare model	13
How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue p	12
Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex	12
Development and validation of a machine learning-based nomogram for prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis	12
Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma	12
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen	12
Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?	11
A narrative review of the current and future role of robotic surgery in liver surgery and transplantation	11
Combination immunotherapy with anti-VEGF/TKI for hepatocellular carcinoma: present and future perspective	11
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatoc	11
Expert consensus on difficult airway assessment	10
Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients	10
Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions	10
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review	10
Gallbladder volvulus	10
Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis	10
A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus	10
Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a mul	9
Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China	9
Surgery for pancreatic cancer: recent progress and future directions	9
Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review	9
Robotic-assisted versus open total pancreatectomy: a propensity score-matched study	9
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	8
Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice	8
Hepatic artery reconstruction technique in liver transplantation: experience with 3,000 cases	8
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	8
Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?	8
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection	8
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up	7
Time to rebuild the doctor-patient relationship in China	7
Conversion surgery for hepatocellular carcinoma in the new era of targeted and immune checkpoint inhibitor therapies	7
Neutrophil extracellular traps contribute to the development of hepatocellular carcinoma in NASH by promoting Treg differentiation	7
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma	7
The upward trend in the immunotherapy utilization for hepatobiliary cancers	7
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	7
Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation	7
Perihilar-cholangiocarcinoma: what really matters?	7
The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF)	7
Intraoperative reperfusion assessment of human pancreas allografts using hyperspectral imaging (HSI)	7
Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma—a cost-effectiveness analysis	7
International consensus guidelines on robotic pancreatic surgery in 2023	7

Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents	7
A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection	7
Revisiting human liver anatomy: dynamic watershed theory	6
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice	6
Automated liver tumor detection in abdominal ultrasonography with a modified faster region-based convolutional neural networks (Faster R-CNN) architecture	6
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma	6
Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases	6
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis	6
Proton beam therapy to bridge or downstage locally advanced hepatocellular carcinoma to living donor liver transplantation	6
Understanding traditional Chinese medicine	6
Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma	6
Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review	6
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid	6
Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis	6
The beneficial impacts of splanchnic vasoactive agents on hepatic functional recovery in massive hepatectomy porcine model	6
Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change	6
Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review	5
The SUPER reporting guideline suggested for reporting of surgical technique	5
Editorial comment: a review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis	5
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study	5
Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?	5
Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic steatohepatitis: new insights from subcutaneous semaglutide	5
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	5
Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis	5
No touch radiofrequency ablation for hepatocellular carcinoma: a conceptual approach rather than an iron law	5
Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives	5
Uncommon indications for associating liver partition and portal vein ligation for staged hepatectomy: a systematic review	5
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	5
Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease	5
Advances in 3D bioprinting technology for liver regeneration	5
A comparative study of pancreas transplantation between type 1 and 2 diabetes mellitus	4
Addressing the variation in hepatic surgery for colorectal liver metastasis	4
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	4
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	4
Pan-peroxisome proliferator-activated receptor agonist lanifibranor as a dominant candidate pharmacological therapy for nonalcoholic fatty liver disease	4
Combined non-alcoholic fatty liver disease and type 2 diabetes in severely obese patients—medium term effects of sleeve gastrectomy versus Roux-en-Y-gastric bypass on disease markers	4
Not yet IDEAL?—evidence and learning curves of minimally invasive pancreaticoduodenectomy	4
Clinical practice guidelines for acute-on-chronic liver failure: are we ready for reaching global consensus?	4
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality	4
Synchronous colorectal liver metastases: therapeutic considerations	4
Validation of the Enhanced Recovery after Surgery (ERAS) society recommendations for liver surgery: a prospective, observational study	4
New guidelines for the treatment of severe acute pancreatitis	4
The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma	4
Predicting post-operative pancreatic fistula: one size may not fit all	4
Semaglutide for nonalcoholic steatohepatitis: closer to a solution?	4
Comparison of alternative arterial anastomosis site during liver transplantation when the recipient’s hepatic artery is unusable	4
Management of recurrent hepatocellular carcinoma after resection	4
Stool banking for fecal microbiota transplantation: ready for prime time?	4
Revolutionizing preclinical research for pancreatic cancer: the potential of 3D bioprinting technology for personalized therapy	4
Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma	4
A simple scoring system to estimate perioperative mortality following liver resection for primary liver malignancy—the Hepatectomy Risk Score (HeRS)	3
Portal inflow reconstruction for liver transplantation with portal vein thrombosis	3
Have we really understood when the efforts of laparoscopic liver resection are justified?—a complexity-based appraisal of the differential benefit	3
The role of the robot-assisted procedure during total pancreatectomy: a viewpoint	3
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology	3
Current status of treatment for colorectal liver metastases in the United Kingdom	3
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection	3
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score: is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged h	3
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections	3
Improvement and development in anatomical hepatectomy for hepatocellular carcinoma	3
Liver cirrhosis and sarcopenia: a dreadful combination	3
Inflammation is king in liver resection for hepatocellular carcinoma	3
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma	3
Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis	3
Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient	3
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions	3
Laparoscopic surgery for colorectal liver metastases: moving forward while keeping feet on the ground	3
Screening for pancreatic cancer—a compelling challenge	3
French editorial from the ACHBPT: blood salvage and autotransfusion during liver transplantation for advanced hepatocellular carcinoma	3
Functional assessment of liver regeneration after major hepatectomy	3
The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study	3
The potential use of extended criteria donors and eligible recipients in liver transplantation for unresectable colorectal liver metastases in Central Sweden	3
The global burden of fatty liver disease: the major impact of China	3
The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma	3
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma—a multicenter propensity score matching analysis	3
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals	3
The challenge of hepatic vein reconstruction in surgical oncology	3
Emergency laparoscopic pancreatoduodenectomy as treatment for pancreatic head cancer-induced acute gastrointestinal hemorrhage, safe or not?	3
Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases	3
Dietary health of medical workers: who’s taking care of it?	3

An important measure taken for China Organ Transplant Response System	3
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts	3
Genome-wide analysis of hepatitis B virus integration in hepatocellular carcinoma: Insights next generation sequencing	3
Roles of the human microbiome in cancer	3
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021	3
Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma	3
Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre)	3
Launching of the Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) in the Sultanate of Oman to manage HBP type of cancers	3
The benefit of curative liver resection with a selective bile duct preserving approach for hepatocellular carcinoma with macroscopic bile duct tumor thrombus	3
Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery	3
Robotic pancreaticoduodenectomy after the learning curve—a new hope	3
Up-to-date global epidemiology of nonalcoholic fatty liver disease	3
Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?	3
A female surgeon’s thoughts on gender attributes in surgery	3
Comment on: simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases	3
The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma	3
Conversion therapy of stage IVb unresectable gallbladder carcinoma	2
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection	2
Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?	2
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma	2
Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis	2
Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic	2
Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism	2
Cholecystectomy increases the risk of metabolic syndrome in the Korean population: a longitudinal cohort study	2
Clinical impact of omega-3 fatty acids (Ω3 FA) supplementation on liver surgery	2
Is it necessary to target lipid metabolism in different organs for effective treatment of NASH?—the results of the Pan-PPAR Lanifibranor trial	2
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment	2
Liver metastasis of pancreatic cancer: the new choice at the crossroads	2
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma	2
Prognosis control surgery	2
Nutritional management after hepatopancreatobiliary surgery	2
Influence of skeletal muscle mass on graft regeneration after living-donor liver transplantation	2
Preservation of aberrant right hepatic arteries does not affect safety and oncological radicality of pancreaticoduodenectomy—own results and a systematic review of the literature	2
NAFLD or MAFLD: the data behind the debate	2
Hepatocellular carcinoma with macrovascular invasion: need a personalized medicine for this complicated event	2
Breast cancer liver metastasis: time to resection and criteria	2
Tenofovir vs. entecavir in reducing hepatocellular carcinoma risk in patients with chronic HBV infection?—Still an unsolved question	2
Choline suppresses hepatocellular carcinoma progression by attenuating AMPK/mTOR-mediated autophagy via choline transporter SLC5A7 activation	2
Is FOLFOX-HAIC superior to transarterial chemoembolization in treating large hepatocellular carcinoma?	2
Tailoring bacterial taxa for immune cell modulation	2
Highlights of constructing liver-relevant in vitro models with 3D bioprinting	2
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?	2
Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases	2
The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A	2
Looking for the right TNM staging system for pancreatic neuroendocrine tumors	2
The role of associating liver partition and portal vein ligation for staged hepatectomy in the management of patients with colorectal liver metastasis	2
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: far from a clinical consensus	2
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications	2
One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysis	2
Liver transplantation for unresectable colorectal liver metastases (CRLM) using extended criteria donor (ECD) grafts: proceed with caution	2
Spontaneous rupture of hepatocellular carcinoma trans-arterial embolization or hepatectomy?	2
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma	2
Advances in the construction of in vitro liver tissue models using 3D bioprinting technology	2
Comment on: Failure to rescue in patients with distal pancreatectomy: a nationwide analysis of 10,632 patients	2
A haemorrhagic cholecystitis presenting as obstructive jaundice	2
Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT	2
Three-dimensional bioprinted liver tissue for transplantation: hope or hype?	2
Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience	2
Hepatocellular carcinoma with portal invasion, still a place for liver surgery in the era of immunotherapy?	2
Does laparoscopic resection for colorectal cancer liver metastasis have a long-term oncologic advantage?	2
Extended pancreatoduodenectomy with portal vein and inferior vena cava resection and reconstruction combined with sorafenib for hepatoid carcinoma of the pancreas: a strategy of superextended surgery	2
Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease	2
Age-specific microbiota in altering host inflammatory and metabolic signaling and metabolome based on sex	2
The role of diet in the management of MAFLD—why does a new disease require a novel, individualized approach?	2
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases	2
Progress in TNM staging of pancreatic neuroendocrine tumors	2
Extranodal Rosai Dorfman disease mimicking multiple liver metastases	2
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice	2
An extremely rare phenomenon of mucinous cystic neoplasm of the liver: spontaneous rupture	2
Finding a role for cancer vaccines in pancreatic cancer: a model of resilience	2
The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma	2
Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?	2
Liver metastases “siphon” off immunotherapy response	2
Expert consensus on magnetic recanalization technique for biliary anastomotic strictures after liver transplantation	2